financetom
Business
financetom
/
Business
/
EU charges Microsoft with abusive bundling of Teams with Office
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU charges Microsoft with abusive bundling of Teams with Office
Jun 25, 2024 3:39 AM

BRUSSELS (Reuters) - EU antitrust regulators on Tuesday charged Microsoft ( MSFT ) of illegally bundling its chat and video app Teams with its Office product and say that recent moves by the U.S. tech giant to unbundle the package were insufficient and more needed to be done.

"Microsoft ( MSFT ) has breached EU antitrust rules by tying its communication and collaboration product Teams to its popular productivity applications included in its suites for businesses Office 365 and Microsoft ( MSFT ) 365," the European Commission said in a statement.

"The Commission preliminarily finds that these changes are insufficient to address its concerns and that more changes to Microsoft's ( MSFT ) conduct are necessary to restore competition," it said, referring to Microsoft's ( MSFT ) unbundling of Teams from Office announced in recent months.

The move by the EU competition watchdog was triggered by a 2020 complaint by Salesforce ( CRM )-owned competing workspace messaging app Slack.

Teams was added to Office 365 in 2017 for free and subsequently replaced Skype for Business. Its popularity soared during the pandemic due in part to its video conferencing.

Microsoft ( MSFT ) said it would work to find solutions to address EU regulators' concerns.

(This story has been corrected to say 'insufficient' instead of 'sufficient' in paragraph 1)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer
Sector Update: Consumer
Jul 23, 2024
01:24 PM EDT, 07/23/2024 (MT Newswires) -- Consumer stocks were softer Tuesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) shedding 0.2% and the Consumer Discretionary Select Sector SPDR Fund (XLY) fractionally lower. Redbook US same-store sales rose by 4 .9% from a year earlier in the week ended July 20 after a 4.8% year-over-year increase in the...
US drug industry middlemen defend business model amid accusations of raising patient costs
US drug industry middlemen defend business model amid accusations of raising patient costs
Jul 23, 2024
July 23 (Reuters) - U.S. pharmaceutical industry middlemen defended their role in the healthcare system during a Congressional hearing on Tuesday after committee members accused them of pushing patients toward expensive treatments even when lower-cost options are available. A House Committee on Oversight and Accountability report released earlier on Tuesday said it found evidence that these pharmacy benefit managers force...
Hospital Chain Operator HCA Healthcare Says Positive Q2 Earnings Reflect Strong Demand For Services, Issues Upbeat Annual Outlook
Hospital Chain Operator HCA Healthcare Says Positive Q2 Earnings Reflect Strong Demand For Services, Issues Upbeat Annual Outlook
Jul 23, 2024
On Tuesday, HCA Healthcare Inc. ( HCA ) reported second-quarter revenues of $17.49 billion, up from $15.86 billion a year ago and beating the consensus of $17.05 billion. The hospital chain reported adjusted EPS of $5.50, up from $4.29 a year ago, beating the consensus of $5.36. “The company’s results for the second quarter were positive and reflected strong demand for...
Cellectar Shares Fall as Updated Data For Investigational Radiotherapy Shows Drop in Major Response Rate
Cellectar Shares Fall as Updated Data For Investigational Radiotherapy Shows Drop in Major Response Rate
Jul 23, 2024
01:26 PM EDT, 07/23/2024 (MT Newswires) -- Cellectar Biosciences ( CLRB ) shares were down nearly 19% in recent Tuesday trading after the company released updated data for its investigational radiotherapy Iopofosine I 131, showing a drop in major response rate. As of the May 31 cutoff, Iopofosine I 131 was found to have a major response rate of 56.4%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved